Tecfidera in a Nutshell

Tecfidera is an oral medication and although this medication is not completely understood, researchers believe that Tecfidera inhibits immune system cells and molecules.

Biogen recently reported new data showing the effectiveness of Tecfidera (dimethyl fumarate) in newly diagnosed relapsing-remitting multiple sclerosis (RRMS) patients.

In this 2013 National MS Society video, watch Gabriel Pardo, MD, and Bruce Cohen, MD, discuss Tecfidera and its usage.

Read the all latest Tecfidera news here.

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Leave a Comment

Your email address will not be published. Required fields are marked *